title: Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.
authors.affiliation: Department of Infectious Disease Control, National Institute of Publich Health, Oslo.
authors.forename: P
authors.initials: P
authors.lastname: Aavitsland
authors.forename: G
authors.initials: G
authors.lastname: Bjune
authors.forename: S
authors.initials: S
authors.lastname: Aasen
authors.forename: S
authors.initials: S
authors.lastname: Halvorsen
mesh_terms: D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards; D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects* / Q000276:immunology; D004311:Double-Blind Method; D006801:Humans; D022401:Meningococcal Vaccines; D009422:Nervous System Diseases / Q000139:chemically induced / Q000453:epidemiology; D009664:Norway / Q000453:epidemiology; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D012574:Schools
chemical_list: D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B